Dimensional Fund Advisors LP Raises Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Dimensional Fund Advisors LP lifted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,082 shares of the medical instruments supplier’s stock after purchasing an additional 3,757 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Mettler-Toledo International were worth $191,614,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Mettler-Toledo International by 0.7% during the first quarter. Vanguard Group Inc. now owns 2,534,104 shares of the medical instruments supplier’s stock worth $3,479,806,000 after purchasing an additional 17,826 shares in the last quarter. WCM Investment Management LLC grew its holdings in shares of Mettler-Toledo International by 0.4% during the second quarter. WCM Investment Management LLC now owns 928,095 shares of the medical instruments supplier’s stock worth $1,230,190,000 after purchasing an additional 3,512 shares in the last quarter. FMR LLC grew its holdings in shares of Mettler-Toledo International by 6.7% during the first quarter. FMR LLC now owns 790,755 shares of the medical instruments supplier’s stock worth $1,210,020,000 after purchasing an additional 49,657 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Mettler-Toledo International by 0.6% during the first quarter. Geode Capital Management LLC now owns 500,127 shares of the medical instruments supplier’s stock worth $763,880,000 after purchasing an additional 2,842 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in Mettler-Toledo International by 26.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 326,105 shares of the medical instruments supplier’s stock worth $471,369,000 after buying an additional 67,758 shares in the last quarter. Hedge funds and other institutional investors own 93.11% of the company’s stock.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,049.05 on Friday. The firm has a market cap of $22.74 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 5.33 and a beta of 1.17. Mettler-Toledo International Inc. has a fifty-two week low of $928.49 and a fifty-two week high of $1,615.97. The business has a 50 day moving average price of $1,061.16 and a 200-day moving average price of $1,216.01.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 9th. The medical instruments supplier reported $9.80 EPS for the quarter, beating analysts’ consensus estimates of $9.63 by $0.17. The company had revenue of $942.46 million during the quarter, compared to the consensus estimate of $947.10 million. Mettler-Toledo International had a negative return on equity of 1,852.05% and a net margin of 22.24%. The firm’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $10.18 earnings per share. Research analysts predict that Mettler-Toledo International Inc. will post 39.2 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have issued reports on MTD shares. TheStreet lowered Mettler-Toledo International from a “b-” rating to a “c+” rating in a research note on Tuesday, August 15th. Robert W. Baird cut their target price on Mettler-Toledo International from $1,454.00 to $1,366.00 in a research note on Friday, July 28th. JPMorgan Chase & Co. cut their target price on Mettler-Toledo International from $1,300.00 to $1,100.00 and set a “neutral” rating for the company in a research note on Tuesday, October 17th. The Goldman Sachs Group cut their target price on Mettler-Toledo International from $1,185.00 to $1,030.00 and set a “neutral” rating for the company in a research note on Monday, November 13th. Finally, Stifel Nicolaus cut their target price on Mettler-Toledo International from $1,425.00 to $1,270.00 and set a “buy” rating for the company in a research note on Monday, November 13th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average price target of $1,302.29.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Roland D. Diggelmann bought 315 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The stock was bought at an average price of $1,026.54 per share, for a total transaction of $323,360.10. Following the completion of the acquisition, the director now directly owns 405 shares in the company, valued at $415,748.70. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.40% of the stock is owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.